NEWS
BioNova Supports BIOTECanada initiatives (IRAP & SR&ED)
BioNova is supporting an initiative from BIOTECanada concerning IRAP and expediting SR&ED claims.Two programs which have become instrumental in supporting early stage companies, namely: the Industrial Research Assistance Program (IRAP) and the Scientific Research...
News Release: Health and Life Sciences Companies in Nova Scotia Develop Vaccines, Provide Medical Supplies to Fight COVID-19
Halifax, NS – March 26th, 2020 – As the impact of the novel coronavirus (COVID-19) pandemic continues to grow globally, Nova Scotia's innovative health and life sciences community including IMV Inc., Sona Nanotech, BioVectra and others are ramping up efforts to study...
News Release: IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19
See original release here FOR IMMEDIATE RELEASE Dartmouth, Nova Scotia, March 18, 2020 – IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company (the “Company” or “IMV”), today announced that it is advancing the clinical development of a DPX-based...
News Release: ACOA announces $1.75M for four life sciences companies
See original ACOA news release here Atlantic Canada’s life sciences companies reaching global markets Businesses are commercializing products to improve lives and transform Atlantic Canada’s economy March 2, 2020 – Halifax, Nova Scotia – Atlantic Canada Opportunities...
HUDDLE: Local Startups Pitch To Fix N.S. Healthcare
See original HUDDLE article here HALIFAX—Dr. Brendan Carr, the president and CEO of the Nova Scotia Health Authority, admits the province’s health care system faces some challenging problems. Emergency room closures, doctor recruitment, high cancer rates, and a host...
EVENTS
SOCIAL
Only one day left to get your submissions in to @RocheCanada COVID-19 Innovation Challenge. Deadline is tomorrow, Friday, April 10th. https://t.co/i8aWvUkGbd
The Roche Canada COVID-19 Innovation Challenge is a funding program to support our community in bringing forward innovative ideas to address some of the biggest challenges and issues of the #COVID19 pandemic. Submit your idea by April 10. https://t.co/qh99fpzuhW https://t.co/yHLRr7PafU
According to @GovCanHealth most PPE, including face shields, are Class I medical devices if they are represented for use for medical purposes. Meaning companies require regulatory approval!! @BioNovaNS can help NS companies navigate this process, reach out to us. https://t.co/p7VewvhQDg
ABOUT BIONOVA
Our mandate is to:
- LEAD the development of Health and Life Science in Nova Scotia
- ACCELERATE companies and the business ecosystem
- ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy
OUR SECTOR STRENGTHS
Medical Technologies- Digital Health
- Pharmaceuticals & Vaccines
- Natural Health Products
- BioProducts
Medical Technologies
Digital Health
Pharmaceuticals & Vaccines
Natural Health Products
BioProductsPlease visit our Sector Strengths page to learn more.
OUR ACCELERATION INITIATIVES
BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.